0023

CN:BLUESAIL

蓝帆医疗

  • Stock

Last Close

5.62

08/11 05:15

Market Cap

4.46B

Beta: -

Volume Today

10.00M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
229.08M
-
207.39M
9.47%
179.00M
13.69%
171.47M
4.20%
215.43M
25.63%
334.87M
55.45%
419.21M
25.18%
592.39M
41.31%
946.65M
59.80%
1.02B
7.82%
985.64M
3.43%
average payables
378.06M
-
316.06M
16.40%
202.80M
35.83%
167.51M
17.40%
197.07M
17.65%
381.26M
93.46%
482.53M
26.56%
608.58M
26.12%
624.89M
2.68%
365.66M
41.49%
348.93M
4.57%
average receivables
257.84M
-
269.21M
4.41%
274.18M
1.85%
257.02M
6.26%
259.49M
0.96%
546.57M
110.63%
799.35M
46.25%
1.03B
28.94%
1.10B
7.13%
907.60M
17.80%
902.11M
0.61%
book value per share
2.10
-
2.20
4.83%
2.43
10.71%
2.65
9.14%
2.91
9.68%
10.57
263.15%
8.77
17.03%
10.16
15.84%
10.30
1.39%
10.49
1.79%
9.41
10.28%
capex per share
-0.63
-
-0.15
75.55%
-0.09
39.66%
-0.20
119.61%
-0.52
156.10%
-0.60
14.55%
-0.37
37.95%
-1.25
235.62%
-2.52
102.72%
-0.89
64.69%
-0.76
14.42%
capex to depreciation
-7.28
-
-1.26
82.67%
-1.00
20.92%
-2.20
121.14%
-4.92
123.23%
-3.27
33.62%
-1.92
41.21%
-5.63
193.18%
-7.77
38.06%
-1.83
76.40%
-1.48
19.53%
capex to operating cash flow
-2.21
-
-0.48
78.09%
-0.17
64.28%
-0.61
252.26%
-1.12
84.68%
-0.68
39.56%
-0.46
32.92%
-0.33
28.08%
-1.15
250.86%
-1.81
57.76%
10.62
685.59%
capex to revenue
-0.22
-
-0.05
78.52%
-0.03
37.10%
-0.08
158.75%
-0.16
109.66%
-0.17
2.45%
-0.10
38.27%
-0.15
48.97%
-0.32
108.26%
-0.18
42.52%
-0.16
14.15%
cash per share
0.62
-
0.60
3.40%
0.52
12.49%
0.59
12.79%
0.49
17.48%
2.57
426.90%
2.34
8.97%
4.98
113.36%
3.41
31.63%
2.51
26.35%
1.57
37.57%
days of inventory on hand
68.85
-
55.95
18.73%
52.07
6.93%
71.35
37.02%
83.50
17.03%
97.78
17.10%
81.86
16.28%
100.17
22.36%
95.42
4.74%
76.07
20.28%
89.08
17.10%
days payables outstanding
126.32
-
66.33
47.49%
55.59
16.20%
64.08
15.28%
77.42
20.81%
123.42
59.42%
84.98
31.15%
102.32
20.40%
39.41
61.48%
22.14
43.83%
36.41
64.46%
days sales outstanding
65.85
-
70.75
7.44%
60.67
14.24%
74.54
22.86%
59.24
20.53%
115.20
94.46%
79.95
30.60%
60.30
24.59%
40.89
32.19%
67.55
65.21%
66.47
1.59%
debt to assets
0.24
-
0.17
27.28%
0.03
-
0.29
775.55%
0.28
4.96%
0.33
17.60%
0.22
32.40%
0.20
8.30%
0.25
21.93%
debt to equity
0.47
-
0.27
42.97%
0.04
-
0.48
1,006.83%
0.44
8.23%
0.57
29.78%
0.35
37.46%
0.30
14.07%
0.40
32.72%
dividend yield
0.02
-
0.01
44.96%
0.01
19.47%
0.02
110.32%
0.02
7.24%
0.01
16.22%
0.01
19.77%
0.01
17.59%
0.03
106.87%
0.01
72.82%
0.08
870.62%
earnings yield
0.02
-
0.02
6.63%
0.03
64.37%
0.03
21.44%
0.04
15.16%
0.03
7.02%
0.04
29.05%
0.09
105.42%
0.07
19.62%
-0.05
168.47%
-0.08
75.97%
enterprise value
3.05B
-
4.03B
32.12%
6.53B
62.15%
5.67B
13.18%
5.56B
1.89%
12.47B
124.13%
13.11B
5.14%
22.09B
68.56%
17.55B
20.55%
9.00B
48.72%
9.37B
4.15%
enterprise value over ebitda
26.33
-
25.08
4.73%
21.79
13.12%
20.98
3.74%
17.61
16.06%
21.37
21.35%
14.80
30.75%
5.22
64.72%
4.42
15.42%
29.50
568.00%
251.43
752.42%
ev to operating cash flow
22.76
-
26.68
17.19%
24.99
6.32%
34.58
38.39%
24.44
29.33%
19.20
21.45%
16.74
12.78%
6.02
64.06%
7.82
29.90%
18.20
132.87%
-128.61
806.56%
ev to sales
2.28
-
2.62
14.92%
4.33
64.96%
4.40
1.65%
3.53
19.77%
4.70
33.13%
3.77
19.74%
2.81
25.55%
2.16
22.90%
1.84
15.15%
1.90
3.59%
free cash flow per share
-0.34
-
0.16
147.73%
0.44
170.62%
0.13
70.50%
-0.06
143.84%
0.28
591.03%
0.44
56.99%
2.55
476.40%
-0.33
112.87%
-0.40
21.64%
-0.83
108.70%
free cash flow yield
-0.06
-
0.02
134.28%
0.03
65.22%
0.01
66.11%
-0.00
145.56%
0.02
498.28%
0.04
86.70%
0.12
231.79%
-0.02
116.66%
-0.05
154.38%
-0.12
142.65%
graham net net
-0.78
-
0.10
113.23%
0.43
316.33%
0.59
38.48%
0.30
50.10%
-2.94
1,089.67%
-1.84
37.27%
-1.08
41.42%
-1.61
49.39%
-1.65
2.11%
-3.25
97.17%
graham number
2.17
-
2.53
16.74%
4.38
72.64%
4.70
7.41%
5.18
10.24%
10.57
104.03%
10.03
5.11%
20.40
103.32%
16.18
20.66%
9.34
42.27%
10.89
16.53%
income quality
2.85
-
2.45
14.13%
1.55
36.52%
0.91
41.49%
1.13
23.94%
1.83
62.19%
1.51
17.54%
2.08
38.19%
1.94
6.70%
-1.33
168.35%
0.13
109.66%
intangibles to total assets
0.13
-
0.06
48.66%
0.06
2.18%
0.06
3.44%
0.05
15.41%
0.59
1,050.19%
0.58
2.04%
0.39
32.82%
0.26
32.08%
0.31
18.40%
0.32
1.21%
interest coverage
1.98
-
2.72
37.21%
48.30
1,678.04%
478.15
889.86%
130.22
72.77%
4.81
96.31%
4.97
3.51%
21.16
325.30%
27.32
29.15%
-1.42
105.20%
interest debt per share
1.01
-
0.63
37.28%
0.01
98.50%
0.00
90.28%
0.13
13,821.78%
5.13
3,873.12%
3.95
23.06%
5.95
50.79%
3.78
36.49%
3.32
12.15%
3.80
14.45%
inventory turnover
5.30
-
6.52
23.04%
7.01
7.45%
5.12
27.02%
4.37
14.55%
3.73
14.60%
4.46
19.44%
3.64
18.27%
3.83
4.97%
4.80
25.44%
4.10
14.60%
invested capital
0.47
-
0.27
42.97%
0.04
-
0.48
1,006.83%
0.44
8.23%
0.57
29.78%
0.35
37.46%
0.30
14.07%
0.40
32.72%
market cap
2.88B
-
4.05B
40.68%
6.80B
67.83%
5.96B
12.40%
5.74B
3.67%
10.65B
85.64%
11.67B
9.58%
20.38B
74.60%
16.66B
18.24%
7.84B
52.95%
6.80B
13.25%
net current asset value
-201.20M
-
298.70M
248.46%
455.11M
52.37%
553.01M
21.51%
356.50M
35.53%
-1.65B
564.19%
-1.35B
18.37%
-37.83M
97.20%
-36.31M
4.02%
-897.83M
2,372.98%
-2.32B
157.88%
net debt to ebitda
1.45
-
-0.15
110.24%
-0.90
502.45%
-1.06
18.16%
-0.55
47.70%
3.11
661.28%
1.62
47.91%
0.41
74.99%
0.22
44.70%
3.81
1,597.69%
69.04
1,713.52%
net income per share
0.10
-
0.13
30.00%
0.35
169.23%
0.37
5.71%
0.41
10.81%
0.47
14.63%
0.51
8.51%
1.82
256.86%
1.13
37.91%
-0.37
132.74%
-0.56
51.35%
operating cash flow per share
0.29
-
0.32
11.59%
0.54
68.93%
0.33
37.66%
0.46
38.67%
0.88
89.51%
0.81
7.50%
3.80
366.69%
2.20
42.22%
0.49
77.62%
-0.07
114.61%
payables turnover
2.89
-
5.50
90.43%
6.57
19.33%
5.70
13.26%
4.71
17.22%
2.96
37.27%
4.29
45.24%
3.57
16.94%
9.26
159.61%
16.49
78.02%
10.02
39.19%
receivables turnover
5.54
-
5.16
6.92%
6.02
16.60%
4.90
18.61%
6.16
25.83%
3.17
48.58%
4.57
44.08%
6.05
32.60%
8.93
47.47%
5.40
39.47%
5.49
1.62%
research and ddevelopement to revenue
0.02
-
0.01
16.18%
0.01
12.55%
0.03
150.67%
0.03
2.70%
0.05
59.44%
0.06
12.96%
0.04
34.83%
0.05
46.03%
0.07
33.00%
0.06
17.96%
return on tangible assets
0.03
-
0.04
47.83%
0.12
194.91%
0.12
0.13%
0.12
5.11%
0.07
42.03%
0.09
31.56%
0.17
92.25%
0.09
45.04%
-0.03
136.76%
-0.05
55.85%
revenue per share
2.84
-
3.23
13.79%
3.10
4.06%
2.63
15.13%
3.22
22.15%
3.60
11.80%
3.62
0.52%
8.14
125.29%
7.93
2.66%
4.87
38.57%
4.85
0.32%
roe
0.05
-
0.06
24.01%
0.14
143.20%
0.14
3.14%
0.14
1.03%
0.04
68.43%
0.06
30.78%
0.18
208.06%
0.11
38.76%
-0.04
132.17%
-0.06
68.70%
roic
0.02
-
0.04
137.97%
0.14
239.58%
0.14
3.52%
0.14
0.80%
0.03
77.25%
0.04
34.76%
0.23
439.71%
0.22
4.26%
-0.01
105.60%
-0.04
211.44%
sales general and administrative to revenue
0.01
-
0.01
3.83%
0.02
58.74%
0.01
37.50%
0.02
66.83%
0.01
13.16%
0.02
20.76%
0.00
74.68%
0.02
325.52%
0.02
24.73%
0.07
202.74%
shareholders equity per share
2.10
-
2.20
4.83%
2.43
10.71%
2.65
9.14%
2.91
9.68%
10.57
263.15%
8.77
17.03%
10.16
15.84%
10.30
1.39%
10.49
1.79%
9.41
10.28%
stock based compensation to revenue
tangible asset value
742.42M
-
942.61M
26.97%
1.09B
15.59%
1.20B
10.47%
1.33B
10.83%
289.83M
78.27%
781.48M
169.63%
3.19B
307.85%
6.07B
90.29%
5.58B
7.93%
4.60B
17.69%
tangible book value per share
1.58
-
1.99
25.66%
2.24
12.81%
2.46
9.78%
2.72
10.70%
0.39
85.57%
0.81
106.90%
3.30
305.81%
5.93
79.77%
5.55
6.42%
4.53
18.39%
working capital
21.38M
-
310.22M
1,350.72%
464.87M
49.85%
566.01M
21.76%
374.00M
33.92%
937.22M
150.59%
787.27M
16.00%
3.53B
347.79%
3.16B
10.44%
2.14B
32.09%
-139.09M
106.49%

All numbers in (except ratios and percentages)